[1] Respiratory syncytial viral infection in children with compromised immune function

[2] Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

[3] The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats

[4] Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections

[5] Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children

[6] Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

[7] Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat

[8] Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells

[9] The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses